uniQure N.V. - Ordinary Shares — Quarterly Financial Statistics (NASDAQ:QURE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -44.1 M-39.9 M-16.4 M-77.57 M-38.24 M79.18 M -53.03 M Cash from investing activities 20.1 M73.07 M26.58 M-441.37 M98.56 M— — Cash from financing activities 80.67 M44 K332.24 M2.45 M550 K— — Free cash flow -44.1 M-39.9 M-16.4 M-77.57 M-38.24 M79.18 M -53.03 M

News

Spyre Therapeutics (SYRE) Down 16.6% Since Last Earnings Report: Can It Rebound?

QURE Submits Application for Gene Therapy for Huntington's Disease

uniQure Filed for Huntington's Approval. Acceptance Is the Catalyst, Analyst Says - uniQure (NASDAQ:QURE)

UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle

Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?

THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade) (NYSE:THQ)

Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes (NDX)

QURE Q2 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y

uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

Bristol Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth

uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix

Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?